With over 20 years of clinical operations experience, Brian brings deep knowledge of clinical program management and extensive R&D cross-functional expertise through all phases of drug development. Most recently, Brian headed a clinical operations program in rare diseases as an Associate Director at Amgen, and prior to its acquisition, Horizon Therapeutics. Brian earned an M.S. from Northwestern University’s Kellogg School of Biotechnology and his B.S. from Michigan State University.